-
Transcriptomics-driven classification of ALAL
Study
EGAS00001007967
-
Limited Association between HRR Gene Alterations and HRD in Molecular Tumor Board Cancer Samples: Who should be tested for HRD?
Study
EGAS00001008063
-
Molecular subtypes of pancreatic neuroendocrine tumors mutated in MEN1/DAXX/ ATRX explain biological variability
Study
EGAS00001008272
-
A transcriptomic approach to understand patient susceptibility to pneumonia after abdominal surgery
Study
EGAS00001007229
-
Genomic and epigenomic characterization of juvenile myelomonocytic leukemia (JMML)
Study
EGAS00001002511
-
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma
Study
EGAS00001005328
-
Integrated genomic analyses reveal molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Study
EGAS00001005503
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations
Study
EGAS00001006034
-
THAP11 mutations in a patient with a cblX-like phenotype implicates THAP11 in the regulation of cobalamin metabolism and early vertebrate development
Study
EGAS00001002201
-
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
Study
EGAS00001004212
-
European BestAgeing Study on microRNA candidates for cardiovascular disease
Study
EGAS00001008346
-
Tracking the evolution of Therapy-Related Myeloid Neoplasms using chemotherapy signatures
Study
EGAS00001006903
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Deep single-cell RNA sequencing data for 12346 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive NSCLC patients
Study
EGAS00001002430
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
Whole-genome Sequencing Suggests Mechanisms for 22q11.2 deletion-associated Parkinson’s disease
Study
EGAS00001002275
-
Multi-Layered Molecular Profiling Informs the Diagnosis and Targeted Therapy of Desmoplastic Small Round Cell Tumor
Study
EGAS00001007934
-
Whole genome sequencing of tumor samples from advanced pre-treated NSCLC patients recruited in a phase I/II single-arm trial utilising CVA21, an oncolytic coxsackie virus, in combination with pembrolizumab.
Study
EGAS00001008258
-
Sequencing of paediatric High Grade Gliomas and DIPG
Study
EGAS00001002314
-
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down Syndrome
Study
EGAS00001002410